» Articles » PMID: 31372003

Asthma Impacts on Workplace Productivity in Employed Patients Who Are Symptomatic Despite Background Therapy: a Multinational Survey

Overview
Publisher Dove Medical Press
Date 2019 Aug 3
PMID 31372003
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Asthma affects millions of people worldwide, with many patients experiencing symptoms that affect their daily lives despite receiving long-term controller medication. Work is a large part of most people's lives, hence this study investigated the impact of uncontrolled asthma on work productivity in adults receiving asthma maintenance therapy. An online survey was completed by employed adults in Brazil, Canada, Germany, Japan, Spain and the UK. Participants were confirmed as symptomatic using questions from the Royal College of Physicians' 3 Questions for Asthma tool. The survey contained the Work Productivity and Activity Impairment - Specific Health Problem questionnaire and an open-ended question on the effect of asthma at work. Of the 2,055 patients on long-term maintenance therapy screened, 1,598 were symptomatic and completed the survey. The average percentage of work hours missed in a single week due to asthma symptoms was 9.3%, ranging from 3.5% (UK) to 17.4% (Brazil). Nearly three-quarters of patients reported an impact on their productivity at work caused by asthma. Overall work productivity loss (both time off and productivity whilst at work) due to asthma was 36%, ranging from 21% (UK) to 59% (Brazil). When asked how asthma made participants feel at work, many respondents highlighted how their respiratory symptoms affect them. Tiredness, weakness and mental strain were also identified as particular challenges, with respondents describing concerns about the perception of colleagues and feelings of inferiority. This study emphasizes the extent to which work time is adversely affected by asthma in patients despite the use of long-term maintenance medication, and provides unique personal insights. Strategies to improve patients' lives may include asthma education, optimizing asthma management plans and running workplace well-being programs. Clinicians, employers and occupational health teams should be more aware of the impact of asthma symptoms on employees, and work together to help overcome these challenges.

Citing Articles

Patient-centred outcomes in severe asthma: fatigue, sleep, physical activity and work.

Ten Have L, Meulmeester F, de Jong K, Ten Brinke A Eur Respir Rev. 2025; 34(175).

PMID: 40044187 PMC: 11880904. DOI: 10.1183/16000617.0122-2024.


Anti-interleukin-5/anti-interleukin-5 receptor α treatment improves self-reported work productivity in patients with severe eosinophilic asthma: a prospective cohort trial.

Brinkmann L, Fuge J, Welte T, Suhling H, Drick N ERJ Open Res. 2024; 10(6).

PMID: 39588077 PMC: 11587120. DOI: 10.1183/23120541.00374-2024.


Health-related quality of life in severe hypersensitivity reactions: focus on severe allergic asthma and hymenoptera venom anaphylaxis-a cross-sectional study.

Ricciardi L, Silvestro O, Martino G, Catalano A, Vicario C, Lund-Jacobsen T Front Psychol. 2024; 15:1394954.

PMID: 39246313 PMC: 11377323. DOI: 10.3389/fpsyg.2024.1394954.


Environmental, healthcare and societal impacts of asthma: a UK model-based assessment.

Orlovic M, Tzelis D, Guerra I, Bar-Katz V, Woolley N, Bray H ERJ Open Res. 2024; 10(4).

PMID: 39040585 PMC: 11261382. DOI: 10.1183/23120541.00577-2023.


The relationship between neighborhood economic deprivation and asthma-associated emergency department visits in Maryland.

Akinyemi O, Weldeslase T, Odusanya E, Fasokun M, Agboola B, Andine T Front Allergy. 2024; 5:1381184.

PMID: 38903705 PMC: 11188351. DOI: 10.3389/falgy.2024.1381184.


References
1.
Szucs T, Anderhub H, Rutishauser M . The economic burden of asthma: direct and indirect costs in Switzerland. Eur Respir J. 1999; 13(2):281-6. DOI: 10.1034/j.1399-3003.1999.13b10.x. View

2.
Reilly M, Zbrozek A, Dukes E . The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993; 4(5):353-65. DOI: 10.2165/00019053-199304050-00006. View

3.
Alexopoulos E, Burdorf A . Prognostic factors for respiratory sickness absence and return to work among blue collar workers and office personnel. Occup Environ Med. 2001; 58(4):246-52. PMC: 1740117. DOI: 10.1136/oem.58.4.246. View

4.
Birnbaum H, Berger W, Greenberg P, Holland M, Auerbach R, Atkins K . Direct and indirect costs of asthma to an employer. J Allergy Clin Immunol. 2002; 109(2):264-70. DOI: 10.1067/mai.2002.121310. View

5.
Cisternas M, Blanc P, Yen I, Katz P, Earnest G, Eisner M . A comprehensive study of the direct and indirect costs of adult asthma. J Allergy Clin Immunol. 2003; 111(6):1212-8. DOI: 10.1067/mai.2003.1449. View